Alzheimer's disease Trials in Fukuoka, Japan
Conditions / Alzheimer's disease / Fukuoka, Japan
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02051608 | A Study of Gantenerumab in Participants With Mild Alzheimer Disease | COMPLETED | PHASE3 |
| NCT03114657 | A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) | TERMINATED | PHASE3 |
| NCT06653153 | A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01127633 | Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT02484547 | 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT02245737 | An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease | TERMINATED | PHASE2/PHASE3 |
| NCT02972658 | A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia | TERMINATED | PHASE3 |
| NCT00348309 | Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease | COMPLETED | NA |
| NCT00594568 | Effect of LY450139 on the Long Term Progression of Alzheimer's Disease | COMPLETED | PHASE3 |
| NCT04241068 | A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 | TERMINATED | PHASE3 |